Skip to main content
AVBP logo

AVBP · ArriVent BioPharma, Inc. · Held by Funds

Track AVBP — free
$18.85 +0.91 (+5.07%) At close · Oct 20
Market Cap
$921.31M
Shares
49.31M
Volume · Oct 20 817.87K Avg daily vol (3M) 1M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of AVBP by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 12.41% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.31% 1,141,314
Index ETFs 10.09% 4,976,771
Active ETFs 0.17% 85,520
Active funds 5.58% 2,753,722
Unclassified 0.04% 19,622
All registered funds 18.21% 8,976,949
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding AVBP

151 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 151 positions
Key facts CIK 1868279 CUSIP 04272N102 13F (30d) 10 filings 10 filers Visit website Investor relations